海普瑞(09989.HK)附属依诺肝素钠注射液产品获得玻利维亚国家药理学委员会上市批准
海普瑞药业(09989.HK)公布,旗下全资附属深圳市天道医药,作为供应商生产的依诺肝素钠注射液产品Novonox,已获得玻利维亚国家药理学委员会的上市批准。
Novonox(依诺肝素)适用於血栓栓塞性疾病(深静脉血栓)患者的预防;髋关节或膝关节的外科矫形手术;还适用於髋关节置换术後住院期间或出院;後长期预防静脉性血栓疾病;高风险腹部、妇科或泌尿手术;结直肠手术;深静脉血栓形成(DVT)的医学预防;中度风险以上深静脉栓塞患者,因中重度急性心功能不全(NYHA III或IV型心衰)导致卧床不起的患者,显示急性呼吸衰竭或并发不需要机械通气支持的慢性呼吸功能不全,排除感染性休克的急性呼吸道感染需要短期预防深静脉血栓。
Novonox同样适用於伴或不伴肺栓塞的深静脉血栓治疗;不稳定心绞痛或无Q波改变的心肌梗死治疗,可以联合阿司匹林用药;急性st段抬高型心肌梗死(STEMI)的治疗,包括药物治疗以及随後进行经皮冠;状动脉介入治疗(PCI)患者。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.